WO2002069984A3 - Use of hyaluronic acid uronides for the treatment of inflammatory processes - Google Patents

Use of hyaluronic acid uronides for the treatment of inflammatory processes Download PDF

Info

Publication number
WO2002069984A3
WO2002069984A3 PCT/DE2002/000688 DE0200688W WO02069984A3 WO 2002069984 A3 WO2002069984 A3 WO 2002069984A3 DE 0200688 W DE0200688 W DE 0200688W WO 02069984 A3 WO02069984 A3 WO 02069984A3
Authority
WO
WIPO (PCT)
Prior art keywords
uronides
treatment
hyaluronic acid
inflammatory processes
fostering
Prior art date
Application number
PCT/DE2002/000688
Other languages
German (de)
French (fr)
Other versions
WO2002069984A2 (en
Inventor
Peter-Juergen Mueller
Albert Haertl
Waltraud Hertel
Joerg-Hermann Ozegowski
Original Assignee
Knoell Hans Forschung Ev
Univ Schiller Jena
Peter-Juergen Mueller
Albert Haertl
Waltraud Hertel
Joerg-Hermann Ozegowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoell Hans Forschung Ev, Univ Schiller Jena, Peter-Juergen Mueller, Albert Haertl, Waltraud Hertel, Joerg-Hermann Ozegowski filed Critical Knoell Hans Forschung Ev
Priority to EP02748304A priority Critical patent/EP1408990A2/en
Publication of WO2002069984A2 publication Critical patent/WO2002069984A2/en
Publication of WO2002069984A3 publication Critical patent/WO2002069984A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The invention relates to the intracorporeal use of highly active, low molecular weight hyaluronic acid uronides of biotechnological origin for the treatment of inflammatory processes and fostering health in humans and animals.
PCT/DE2002/000688 2001-03-02 2002-02-21 Use of hyaluronic acid uronides for the treatment of inflammatory processes WO2002069984A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP02748304A EP1408990A2 (en) 2001-03-02 2002-02-21 Use of hyaluronic acid uronides for the treatment of inflammatory processes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10111165.7 2001-03-02
DE10111165A DE10111165A1 (en) 2001-03-02 2001-03-02 Use of hyaluronic acid uronides for the treatment of inflammatory processes

Publications (2)

Publication Number Publication Date
WO2002069984A2 WO2002069984A2 (en) 2002-09-12
WO2002069984A3 true WO2002069984A3 (en) 2003-01-30

Family

ID=7676737

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2002/000688 WO2002069984A2 (en) 2001-03-02 2002-02-21 Use of hyaluronic acid uronides for the treatment of inflammatory processes

Country Status (3)

Country Link
EP (1) EP1408990A2 (en)
DE (1) DE10111165A1 (en)
WO (1) WO2002069984A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352137A1 (en) * 2003-11-04 2005-06-16 Beschorner, Katharina, Dr. Use of sulfated hyaluronic acid
FR2919185B1 (en) * 2007-07-23 2010-09-10 Ard Sa USE OF HYALURONIC ACID FOR THE PREPARATION OF COMPOSITIONS INTENDED TO IMPROVE THE CONDITION OF MUCOUS MEMBRANES
CZ18797U1 (en) 2008-07-08 2008-08-11 Isoline S.R.O. Composition for prevention of jaoint diseases
IT1391251B1 (en) * 2008-10-15 2011-12-01 Innovative Nutrition & Pharma Srl COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243867A2 (en) * 1986-04-28 1987-11-04 Mobay Corporation Compositions for the administration of hyaluronic acid to mammals
EP0295092A2 (en) * 1987-06-12 1988-12-14 Unilever Plc Skin treatment composition
JPH01151462A (en) * 1987-12-09 1989-06-14 Terumo Corp Fluid for peritoneal perfusion
JPH09241637A (en) * 1996-03-14 1997-09-16 Chugai Pharmaceut Co Ltd Composition for removing active oxygen free radical and removal thereof
EP0888776A1 (en) * 1996-03-15 1999-01-07 Takara Shuzo Co. Ltd. A product of heat treatment of uronic acid, food, drink or drug including the product
JPH11124401A (en) * 1997-10-22 1999-05-11 Chisso Corp Production of oligo hyaluronic acid or salt thereof
WO2000038647A1 (en) * 1998-12-23 2000-07-06 Esparma Gmbh Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
WO2002032407A2 (en) * 2000-10-19 2002-04-25 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
DE10053866A1 (en) * 2000-10-27 2002-05-08 Condomi Erfurt Produktions Gmb Biocompatible liquid formulation, containing a mixture of biopolymers, useful as a lubricant in human and veterinary medicine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4223613C2 (en) * 1992-07-17 1994-07-21 Zuckerindustrie Verein Process for the production of unsaturated uronides from pectin-containing substances

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243867A2 (en) * 1986-04-28 1987-11-04 Mobay Corporation Compositions for the administration of hyaluronic acid to mammals
EP0295092A2 (en) * 1987-06-12 1988-12-14 Unilever Plc Skin treatment composition
JPH01151462A (en) * 1987-12-09 1989-06-14 Terumo Corp Fluid for peritoneal perfusion
JPH09241637A (en) * 1996-03-14 1997-09-16 Chugai Pharmaceut Co Ltd Composition for removing active oxygen free radical and removal thereof
EP0888776A1 (en) * 1996-03-15 1999-01-07 Takara Shuzo Co. Ltd. A product of heat treatment of uronic acid, food, drink or drug including the product
JPH11124401A (en) * 1997-10-22 1999-05-11 Chisso Corp Production of oligo hyaluronic acid or salt thereof
WO2000038647A1 (en) * 1998-12-23 2000-07-06 Esparma Gmbh Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
WO2002032407A2 (en) * 2000-10-19 2002-04-25 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
DE10053866A1 (en) * 2000-10-27 2002-05-08 Condomi Erfurt Produktions Gmb Biocompatible liquid formulation, containing a mixture of biopolymers, useful as a lubricant in human and veterinary medicine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199750, Derwent World Patents Index; AN 1997-539756, XP002210304, OKUBO KAZUYOSHI, YOSHIKI YUMIKO: "Composition for removing active oxygen free radical and removal thereof." *
DATABASE WPI Week 199929, Derwent World Patents Index; AN 1999-341642, XP002210303, SATO IKUO: "Production of oligo hyaluronic acid or salt thereof" *
PATENT ABSTRACTS OF JAPAN vol. 013, no. 414 (C - 635) 13 September 1989 (1989-09-13) *
PATENT ABSTRACTS OF JAPAN vol. 1998, no. 01 30 January 1998 (1998-01-30) *

Also Published As

Publication number Publication date
WO2002069984A2 (en) 2002-09-12
EP1408990A2 (en) 2004-04-21
DE10111165A1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2005123116A3 (en) Compositions and methods for treating or preventing oxalate-related disease
WO2004010952A3 (en) Methods and compositions for treatment of dermal conditions
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
HK1067073A1 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
HK1096392A1 (en) Substituted heterocycles
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
AU2001254624A1 (en) Human coagulation factor vii variants
HK1094320A1 (en) Antiseptic compositions, methods and systems
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2004006858A3 (en) Compounds, compositions, and methods employing same
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
GB0404374D0 (en) Treatment of bacterial infections
WO2004098536A3 (en) Anti-viral activity of cathelicidin peptides
EP1236465A3 (en) Use of legume products for the treatment of external aggressions
WO2002069984A3 (en) Use of hyaluronic acid uronides for the treatment of inflammatory processes
WO2005077397A3 (en) Methods and compositions for treating vascular diseases
WO2005042699A3 (en) Modified polypeptides with therapeutic activity and methods of use
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
WO2005011728A3 (en) Use of soluble cd164 in inflammatory and/or autoimmune disorders
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AU BA BG BR CA CN CU CZ DZ EE GE HR HU ID IL IN IS JP KR LT MA MK MX NO NZ PL PT RO RU SD SG SI SK UA US YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AU BA BG BR CA CN CU CZ DZ EE GE HR HU ID IL IN IS JP KR LT MA MK MX NO NZ PL PT RO RU SD SG SI SK UA US YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2002748304

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002748304

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002748304

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP